AVY
50
2
TROW
51
3
MCO
75
2
CI
52
7
RHI
57
3
PWR
72
2
SHW
65
7
SO
57
2
NKE
30
2
LB
41
7
EQR
59
5
EXPE
91
3
XYL
45
8
ADSK
68
2
KIM
76
2
APH
67
3
CVS
50
2
PEG
67
5
L
64
2
HBI
55
-4
AVY
50
2
TROW
51
3
MCO
75
2
CI
52
7
RHI
57
3
PWR
72
2
SHW
65
7
SO
57
2
NKE
30
2
LB
41
7
EQR
59
5
EXPE
91
3
XYL
45
8
ADSK
68
2
KIM
76
2
APH
67
3
CVS
50
2
PEG
67
5
L
64
2
HBI
55
-4
Financhill
Back

Vertex Pharmaceuticals Vs. Bristol-Myers Squibb Industry Stock Comparison

Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
450.38
Seasonality Move:
11.1%
Buy
58

BMY
Bristol-Myers Squibb

Last Price:
58.24
Seasonality Move:
2.73%
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $450.37. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Bristol-Myers Squibb (BMY) is a Buy

Is Bristol-Myers Squibb a Buy, Sell or Hold?

  • The current Bristol-Myers Squibb [BMY] share price is $58.23. The Score for BMY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $450.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.

BMY Stock Price Chart

What is Bristol-Myers Squibb's stock price today?

  • The Bristol-Myers Squibb share price today is $58.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.97 Sell
Relative Strength Index (14 RSI): 37.76 Sell
Chaikin Money Flow: 44374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (462.09 - 494.97) Sell
Bollinger Bands (100): (465.11 - 492.19) Sell

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.45 Buy
Relative Strength Index (14 RSI): 60.65 Buy
Chaikin Money Flow: 3742798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.86 - 57.74) Buy
Bollinger Bands (100): (45 - 54.6) Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 468.86 Sell
20-day SMA: 479.26 Sell
50-day SMA: 474.44 Sell
200-day SMA: 453.81 Sell
8-day EMA: 465.05 Sell
20-day EMA: 474.27 Sell
50-day EMA: 475.71 Sell
200-day EMA: 452.67 Sell

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.91 Buy
20-day SMA: 55.92 Buy
50-day SMA: 53.36 Buy
200-day SMA: 48.46 Buy
8-day EMA: 57.57 Buy
20-day EMA: 56.26 Buy
50-day EMA: 53.76 Buy
200-day EMA: 50.72 Buy

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.54 per share, and an increase next year of $18.39 per share.

Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.49 per share, and an increase next year of $6.16 per share.

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bristol-Myers Squibb Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):